Filing Details

Accession Number:
0000950170-25-033845
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-05 17:19:35
Reporting Period:
2025-03-05
Filing Date:
2025-03-05
Accepted Time:
2025-03-05 17:19:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1347178 Vanda Pharmaceuticals Inc. VNDA Pharmaceutical Preparations (2834) 030491827
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1355537 Hristos Mihael Polymeropoulos 2200 Pennsylvania Avenue Nw
Suite 300E
Washington DC 20037
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-03-05 5,000 $5.01 2,280,731 No 4 P Direct
Common Stock Acquisiton 2025-03-05 5,000 $5.03 2,285,731 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct